Aravax Company
Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.
Headquarters:
Melbourne, Victoria, Australia
Founded Date:
2015
Employee Number:
11-50
Last Funding Type:
Seed
Investor Type:
For Profit
Investors Number:
2
Technology:
Cancer
Funding Status:
Seed
Industry:
PharmTech